Ops Manager
CurrentTriomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our GenAI engine, OncoLLM™—an advanced family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities. Our current partners range from large NCI-designated comprehensive cancer centers to regional community oncology practices, and we are backed by leading investors such as Lightspeed, Nexus, General Catalyst and Y Combinator.